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Introduction 
Saturated fatty acid (SFA) intake has been considered to be atherogenic, and reducing 
SFA intake is recommended to prevent atherosclerotic diseases.1 Yet, recent 
meta-analyses have indicated that greater dietary intake of SFA per se may not be 
associated with increased risk of coronary disease2, 3, though another meta-analysis 
showed that replacing SFA intake with polyunsaturated fatty acids (PUFA) intake was 
inversely associated with coronary events.4 Several cohort studies, but not all, have 
reported an inverse association between dietary SFA and risk of ischemic stroke and/or 
intraparenchymal haemorrhage.3 Thus, the role of SFA intake in the development of 
both coronary diseases and stroke remains under debate. 
 Compared with Westerners, Asian people traditionally consume less 
SFA-containing foods, as shown in the Seven Countries Study5 and also in later 
studies.6, 7 The low SFA intake amongst Asians has been believed to be one reason why 
they have lower mortality from coronary disease than Westerners. However, no 
prospective studies have been conducted to examine the association of dietary SFA 
intake with incident stroke and coronary disease in Asians, except for intraparenchymal 
haemorrhage.6  
The Japan Public Health Center-based prospective (JPHC) Study is one of the 
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largest prospective studies in Japan, with systematic incidence registry of cardiovascular 
disease. An advantage of this study included enough number of population to study 
subtypes of stroke (ie, lacunar, large artery occlusive or embolic infarction, and 
subarachnoid, deep or lobar intraparenchymal haemorrhage), which is often hard to 
study in Western cohorts. The population is also unique in that they have very low SFA 
intake, and high stroke and low coronary disease incidence. Our hypotheses were that 
low SFA intake is associated with elevated risk of lacunar infarction and deep 
intraparenchymal haemorrhage, and high SFA intake with elevated risk of coronary 
heart disease. 
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Methods 
Study cohort 
The JPHC Study is an ongoing cohort study comprising a community-based sample of 
140,420 persons (68,722 men and 71,698 women) in Japan. Details of the JPHC Study 
protocol were described elsewhere.8 Briefly, the JPHC Study included two sub-cohorts 
based on Public Health Center areas; Cohort I (started in 1990, 5 Public Health Center 
areas, participants aged 40-59) and Cohort II (started in 1993, 6 PHC areas, aged 
40-69); however, participants in 2 Public Health Center areas (Tokyo and Osaka) were 
excluded from the current study because the follow-up data were incomplete. Thus, 
116,896 subjects, all residents living in the study areas at baseline, were eligible for 
follow-up. Participants were asked to complete self-administered questionnaires about 
their lifestyles and medical histories. Informed consent was obtained before participants 
completed the questionnaire, or sometimes from community leaders instead of 
individuals, as this had been in common practice for informed consent in Japan at that 
time. The JPHC study was approved by the institutional review boards of the National 
Cancer Center and the University of Tsukuba.  
 
Baseline questionnaires 
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A self-administrated questionnaire was distributed to all residents living in the study 
areas aged 40-59 for Cohort I in 1990 and those aged 40-69 for Cohort II in 1993. The 
questionnaire included demographic characteristics, medical history, smoking, drinking 
and dietary habits. A five-year follow-up questionnaire, which includes food frequency 
questionnaire (FFQ), was distributed to all eligible study subjects in 1995 for Cohort I 
and in 1998 for Cohort II. Of these, 92,905 persons (79%) returned their follow-up 
questionnaire. We excluded persons who lost or refused follow-up (n=226); who had 
histories of myocardial infarction, angina pectoris, stroke or cancer based on the first or 
5-year follow-up questionnaires or who were found in the stroke/coronary heart disease 
registry (n=7,964), or who did not satisfactorily complete their dietary questionnaire 
(n=1,114). We further excluded persons with total energy intake <1 percentile or >99 
percentile (n=1,670). Ultimately, 81,931 (38,084 men and 43,847 women) were 
included in this study. 
The FFQ in the 5-year follow-up of cohorts I and II was used to determine the 
dietary intake of SFA and other nutrients/foods. The FFQ included 138 food items and 4 
choices for frequency of intake was offered for each item. The nutrients that each food 
item contained were mostly estimated by the Japan Food Table 5th version. Fatty acids 
were estimated by a JPHC study food table, which was largely based on the Japan Food 
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Table 4th version9, since the 5th version did not include fatty acids. The intake of SFA 
was then calculated by multiplying the frequency scores and estimated SFA for each 
food, and summing across all 138 items. Validation of FFQ was tested comparing SFA 
determined by FFQ and that by dietary records: the Spearman’s correlation coefficients 
between energy adjusted SFA derived from FFQ and dietary records were 0.61 amongst 
men and 0.60 amongst women in Cohort I9 and 0.62 amongst men and 0.51 amongst 
women in Cohort II10. The mean intake of SFA derived from FFQ was 11-31% higher 
than that from dietary records. Reproducibility of FFQ was also confirmed for Cohort II 
at an approximately one-year interval, and was fairly good (Spearman r=0.61 amongst 
men and 0.53 amongst women).10 All dietary variables were adjusted for energy intake 
using the nutrient residual model.11 
 
Stroke and coronary heart disease registries 
A total of 78 hospitals formed the register of events within the 9 PHC areas. All were 
major hospitals with the capability of treating patients with acute coronary heart disease, 
stroke or cancer events. Ninety-seven percent of strokes and 92% of myocardial 
infarctions in the 9 PHC areas were treated at these 78 registry hospitals. Physicians in 
the hospitals, PHCs, or investigators, blinded to the patients’ lifestyle data, reviewed the 
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medical records of cohort participants at each hospital and extracted clinical information 
including brain images, electrocardiogram and enzymes, onto cohort-specific 
registration forms. 
Stroke was confirmed according to the criteria of the National Survey of 
Stroke12, which requires the presence of focal neurological deficits of sudden or rapid 
onset lasting at least 24 hours or until death. Strokes were classified according to 
subtypes; i.e., intraparenchymal haemorrhage (deep or lobar), subarachnoid 
haemorrhage, or cerebral infarction (large-artery thrombotic, lacunar or embolic).13 
Almost all registered hospitals were equipped with CT and/or MRI scans. Imaging was 
available for 98% of registered stroke events. 
Myocardial infarction was confirmed in the medical records according to the 
criteria of the Monitoring Trends and Determinants of Cardiovascular Disease 
(MONICA) project14, which requires typical chest pain and evidence from 
electrocardiogram and/or cardiac enzymes. For cases with typical prolonged chest pain 
(>20 minutes) but not confirmed by electrocardiograms or cardiac enzymes (11% of 
total myocardial infarctions), a possible myocardial infarction diagnosis was made and 
these were included in myocardial infarction cases. Sudden cardiac death was defined as 
a death of unknown origin that occurred within 1 hour from onset of event. 
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For analysis, only first-ever stroke (regardless of subtype) or coronary heart 
disease (myocardial infarction or sudden cardiac death) events during follow-up were 
included; recurrent events were excluded. If one person suffered both coronary heart 
disease and stroke, both events were included. 
 
Statistical analyses 
Follow-up started from completion of the 5-year questionnaire, and ended at the date of 
death, emigration, incident stroke or coronary heart disease event, or end of 2009 (for 
Cohort I) or end of 2007 (for Cohort II), whichever came first. The incidence rates of 
each outcome were calculated according to quintiles of energy-adjusted SFA intake. 
Hazard ratios (HR) with 95% confidence intervals (CI) were calculated after adjustment 
for age, sex, and other covariates with Cox proportional hazard models. The covariates 
included cohort, baseline body mass index (quintile), smoking status (never, ex-, current 
smoker of 1-<20, 20-<30 and 30 cigarettes/day or more) , alcohol intake (0, 1-150, 
151-300, 301-450 and 451 g/wk or more), sports at leisure time (rarely, 1-3/month, 
1-2/week, 3-4/week or more), walking and standing time (<1, 1-3, 3 hr/day or more), 
perceived mental stress (low, medium, high), employment status (non-employed or 
employed), total energy intake (quintile), and quintiles of energy-adjusted dietary 
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intakes of carbohydrate, cholesterol, vegetables, fruit, and calcium. We did not include 
MUFAand PUFA in the model, so the results should be interpreted as the association of 
SFA in exchange for the average combination of other types of fat than SFA (ie, MUFA 
and PUFA). We also did not include serum lipids, hypertension or diabetes, since these 
could be potential mediators for the relation between SFA intake and cardiovascular 
outcomes. The linear trend of HRs across quintiles was tested by an ordinal variable (-2, 
-1, 0, +1, +2) for successive quintiles. Multiplicative interactions with sex were tested 
using a cross-product term. The proportional hazards assumption was tested using time 
by SFA interaction terms and was not violated for each outcome. 
We used SAS version 9.1.3 Service Pack 4 (SAS Institute Inc., Cary, NC) for 
the analyses. All probability values for statistical tests were two-tailed and values of 
p<0.05 were regarded as statistically significant.  
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Results 
The average age was 56.7 years and the median SFA intake was 16.3 g. Most 
risk/dietary factors at baseline were correlated with energy-adjusted SFA intake as 
shown in Table 1. During follow-up of 81,932 persons for a mean of 11.1 years 
(median=9.9 years), a total of 3,192 incident strokes, including 894 intraparenchymal 
haemorrhages, 348 subarachnoid haemorrhages, and 1,939 ischemic strokes (871 
lacunar, 403 large-artery occlusive and 563 embolic), 610 myocardial infarctions and 
116 sudden cardiac deaths were registered. There were no statistical interactions 
between SFA and sex in relation to any cardiovascular outcomes. Therefore, we pooled 
men and women for further analyses. 
As shown in Table 2, SFA intake was inversely associated with age-, sex-, and 
energy-adjusted incidence rates of total stroke, total and deep intraparenchymal 
haemorrhages, ischemic stroke, lacunar infarction, and total cardiovascular disease. On 
the other hand, SFA intake was positively associated with myocardial infarction, but not 
associated with subarachnoid haemorrhage or sudden cardiac death. Further adjustment 
for potential cardiovascular risk factors and nutrients did not change these results 
substantially. There was no interaction between sex and SFA intake in relation to each 
outcome. The sex-specific baseline characteristics, the number of each event, 
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multivariable HRs and p for trend were presented in Supplementary Tables S-1, S-2 and 
S-3. 
We consider hypertension and diabetes to be on the causal pathway between 
SFA and cardiovascular outcomes. When we included treatment for hypertension and 
diabetes in the model, the results were similar for total stroke [multivariable HR for 
highest vs. lowest SFA quintiles =0.82 (0.69-0.98), p for trend=0.01], intraparenchymal 
haemorrhage [HR=0.63(0.45-0.89), p for trend=0.009], lacunar infarction 
[HR=0.81(0.57-1.14), p for trend=0.047] and myocardial infarction 
[HR=1.49(0.99-2.22), p for trend=0.02), but attenuated for ischemic stroke 
[HR=0.91(0.72-1.14), p for trend=0.25]. 
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Discussion 
We observed an inverse relationship between dietary intake of SFA and stroke, 
consistent with some previous studies6, 15-18, but not all19-22. The major strengths of this 
study was the large sample size and availability of stroke subtypes, with 98% of cases 
diagnosed by CT/MRI imaging. We revealed that the inverse association of SFA intake 
with stroke incidence was mainly due to its association with the incidence of deep 
intraparenchymal haemorrhage and lacunar infarction. We also found the association of 
SFA intake with myocardial infarction was positive, the first epidemiological 
observation in Asia, but overall association of SFA intake with total cardiovascular 
disease was inverse, and was driven by its inverse association with stroke. 
 According to the national statistics, Japanese consumed SFA far less than 
Americans (mean intakes were 16-17g among Japanese in 1988-1993 vs. 33g and 22g 
for American men and women, respectively, in 1989-1991)23, 24. In contrast, they have 
much higher incidence of intraparenchymal haemorrhage and lacunar infarction.25 This 
ecological association suggested that their high incidence of both intraparenchymal 
haemorrhage and lacunar infarction could be attributed to low SFA intake since 
haemorrhage and ischemia in the perforator area of the brain is reported to share a 
common pathological condition (i.e., cerebral small vessel pathology called 
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arteriolosclerosis)26, and the presence of arteriolosclerosis has been associated with very 
low blood total cholesterol levels27 attributable in part by low SFA consumption. The 
present finding would be consistent with previous observations that very low blood total 
or LDL-cholesterol28-31, as well as low SFA intake6, 16, were associated with increased 
risk of intraparenchymal haemorrhage.  
We found a positive association between SFA intake and myocardial infarction 
incidence, primarily for men, but not for women, although there was no sex-interaction. 
This is compatible with the result of a previous Japanese study showing a similar sex 
difference in the association between LDL cholesterol and mortality from myocardial 
infarction.32 Major reasons for no association amongst women in the present study 
would be a small number of incident myocardial infarction, but could also relate to the 
attenuated LDL-cholesterol levels by sex-hormones and/or the low incident rate of 
myocardial infarction, which might obscure the adverse coronary effect of high SFA 
intake. Much lower smoking rate of women may also be related.33 The null associations 
in women were in line with the results of other studies such as the Nurses’ Health 
Study34. 
 The distribution of SFA intake in the present study population was significantly 
lower than that for US or European populations, and the cardiovascular disease profile 
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is also different. Therefore, we plotted SFA intake and crude incidence of or mortality 
from haemorrhagic stroke, ischemic stroke and coronary heart disease from the present 
and other published literatures6, 17, 18, 21, 35, 36 where information on absolute amount of 
daily saturated fatty acid intake was available (Figure). Taken together with the other 
studies, there seems to be a threshold around 20g/day of SFA intake for inverse relation 
of SFA intake with stroke, especially with haemorrhagic stroke. There could be an 
optimal level of SFA intake, which should be confirmed by meta-analyses. 
Haemorrhage in the perforator area and lacunar infarction in Western 
populations are not as common as that in Asians.37 The present results may be 
extrapolated to Asian populations that share dietary habits and cardiovascular disease 
profiles with Japan, but not necessarily to populations who with Western lifestyles. 
Although there is no clinical trial evidence, we speculate that people consuming below 
optimal level, if any, of SFA might benefit by modestly increasing their SFA intake. 
However, even in Japanese, this could increase the risk of myocardial infarction 
especially in men. Therefore, recommendation to increase SFA intake cannot made in 
current Japan since both SFA intake and coronary heart disease incidence rate are 
increasing amongst urban Japanese men.38, 39 
We did not include hypertension and diabetes since we consider them as 
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mediators of the associations, as SFA was reported to affect insulin resistance and blood 
pressure.40-42 In the present study, the adjustment for treatment of hypertension and 
diabetes weaken the association between SFA intake and risk of ischemic stroke, 
suggesting that the association was mediated largely by hypertension and diabetes. 
As far as we know, this is the first study to examine the association between 
SFA intake and stroke subtypes. In addition, this is the first study to examine the 
association between SFA intake and risk of myocardial infarction amongst Asians. Other 
strengths of this study include the prospective cohort design, systematic registration of 
stroke and coronary heart disease incidence, high availability of CT/MRI imaging for 
stroke diagnosis, reasonable number of events for statistical power, and multiple 
adjustments for relevant confounders. Limitations of this study, however, warrant 
discussion. First, the use of a FFQ inevitably leads to SFA misclassification, although 
the FFQ was validated by dietary records. Random misclassification of SFA would 
typically attenuate observed associations. Second, persons with low SFA intake in the 
present study were older (women), leaner (men), more hypertensive, less diabetic (men), 
less active, more likely to be current smokers and drinkers (men) and to have fruit 
(women). Although we adjusted for a number of covariates, there would still be a 
potential residual confounding by other dietary and/or socioeconomic factors. Third, the 
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present study was not sufficient to prove the causality. The effects of increasing or 
decreasing SFA intake on the incidence of different types of cardiovascular disease 
should be evaluated ideally by randomized controlled trial. 
In conclusion, we found an inverse association of dietary intake of SFA with 
risk of stroke, primarily for deep intraparenchymal haemorrhage and lacunar infarction, 
and a positive association with risk of myocardial infarction among Japanese. 
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Figure legend 
Comparison of the association of saturated fatty acid intake with crude 
incidence/mortality rates (per 100,000 person-years) of haemorrhagic stroke (Panel A), 
ischemic stroke (Panel B) and coronary heart disease/myocardial infarction (Panel C). 
NHS: Nurses’ Health Study16, ages 34-59, US; HPFS: Health Professional Follow-up 
Study21, 35, ages 40-75, US; CIRCS: Circulatory Risk in Communities Study6, ages 
40-69, Japan; JPHC; Japan Public Health-based Cohort Study (this study), ages 45-74, 
Japan; JACC; Japan Collaborative Cohort Study18, ages 40-79, Japan; LSS: Life Span 
Study17, ages 35-89, Japan; ATBC: Alpha-Tocopherol, Beta-Carotene Cancer 
Prevention Study36, ages 50-69, Finland. The JACC and LSS were mortality studies, 
which made large difference in crude event rates with JPHC Study. The other studies as 
well as JPHC Study were incidence studies.  The ATBC was an intervention study for 
male smokers. Note that characteristics of study population (eg, age range) varied by 
study. 
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Ishikawa, and T. Tagami, Kochi Prefectural Chuo-higashi Public Health Center, 
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Ioka, Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka; S. Sato, 
Osaka Medical Center for Health Science and Promotion, Osaka; N. Yasuda, Kochi 
University, Nankoku; K. Nakamura, Niigata University, Niigata; S. Kono, Kyushu 
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Kobe University, Kobe; the late M. Yamaguchi, Y. Matsumura, S. Sasaki, and S. 
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0.8-11.7 11.8-14.8 14.9-17.7 17.8-21.5 21.6-96.7 p-value†
Median SFA intake‡, g/day 9.6 13.4 16.3 19.4 24.9
Number at risk 16,386 16,386 16,387 16,386 16,386
Age at baseline*, y 57.5(7.7) 56.9(7.7) 56.6(7.8) 56.4(7.8) 55.9(7.9) <0.001
Body mass index, kg/m2 23.5(3.1) 23.6(3.1) 23.6(3.1) 23.5(3.1) 23.6(3.2) 0.005
Systolic blood pressure¶, 133(18) 131(17) 130(17) 130(17) 129(17) <0.001
Diastolic blood pressure¶, 79(11) 78(11) 78(11) 78(11) 77(10) <0.001
Treatment for hypertension, % 21.9 20.0 19.2 18.4 17.9 <0.001
Treatment for diabetes, % 2.2 2.6 3.0 3.3 3.8 <0.001
Serum cholesterol¶, mg/dl 203(36) 206(36) 207(35) 208(35) 209(34) <0.001
Treatment for HC, % 5.7 5.6 5.5 4.5 4.3 <0.001
Current smoker, % 28.9 25.4 23.6 22.7 22.4 <0.001
Current drinker, % 51.2 45.8 41.8 39.7 36.2 <0.001
Sports ≥3 times/wk, % 7.3 8.9 11.2 12.0 14.1 <0.001
Walking/standing ≥3 h/day, % 68.3 65.8 64.9 62.6 61.8 <0.001
High perceived mental stress, 17.1 18.1 17.4 17.8 17.4 0.19
Non-employed, % 6.3 6.7 7.8 8.2 8.7 <0.001
Mean energy intake, Kcal/day 1,956(732) 2,029(688) 2,038(672) 2,037(653) 2,057(742) <0.001
Dietary cholesterol, mg/day 198(146) 275(165) 313(183) 345(205) 388(285) <0.001
Protein, g/day 61(29) 72(30) 76(30) 79(31) 81(35) <0.001
Carbohydrate, g/day 289(101) 286(88) 275(80) 260(72) 232(76) <0.001
MUFA, g/day 13.6(7.8) 19.5(9.2) 22.5(10.3) 25.4(11.4) 30.8(16.3) <0.001
ω-3 PUFA, g/day 2.7(1.7) 3.4(2.0) 3.5(1.9) 3.6(1.9) 3.4(1.8) <0.001
ω-6 PUFA, g/day 7.4(3.9) 9.2(4.5) 9.9(4.5) 10.5(4.6) 11.2(5.5) <0.001
Salt, mg/day 11.9(6.8) 13.2(6.5) 13.1(6.3) 12.9(5.9) 12.2(5.8) <0.001
Calcium, mg/day 389(219) 497(246) 553(264) 602(297) 750(545) <0.001
Vegetable intake, g/day 212(192) 242(188) 239(172) 230(155) 206(148) <0.001
Fruit intake, g/day 231(254) 251(226) 242(207) 219(184) 172(160) <0.001
Meat intake, g/day 28(27) 49(37) 63(46) 78(54) 103(85) <0.001
Dairy intake, g/day 59(80) 122(109) 171(140) 221(183) 379(431) <0.001
¶ Only available for subsample (8,765 men and 16,047 women)
* Sex-adjusted mean
‡ Energy-adjusted values by nutrient residual model.
Table 1.  Baseline cardiovascular risk factors and selected dietary variables in a cohort of  38,084 men and
43,847 women according to quintiles of saturated fatty acid (SFA) intake.
Quintiles of SFA intake‡
Men and women
HC: hypercholesterolemia, SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA:
polyunsaturated fatty acids
Age and sex-adjusted means (unadjusted standard deviations), or age and sex-adjusted percentages
presented unless otherwise indicated.
† p values for overall difference among quintiles based on analysis of covariance 
Q1 Q2 Q3 Q4 Q5 Trend p
9.6 13.4 16.3 19.4 24.9
Person-years 179,635 182,406 182,672 182,019 180,991
817 695 594 540 546
Age, sex, energy-adjusted HR 1.0 0.91(0.82-1.00) 0.83(0.75-0.93) 0.80(0.72-0.90) 0.86(0.77-0.96) <0.001
Multivariable HR (95%CI) 1.0 0.98(0.88-1.10) 0.90(0.79-1.03) 0.83(0.71-0.97) 0.77(0.65-0.93) 0.002
230 186 167 161 150
Age, sex, energy-adjusted HR 1.0 0.85(0.70-1.03) 0.80(0.66-0.98) 0.81(0.66-1.00) 0.79(0.64-0.98) 0.04
Multivariable HR (95%CI) 1.0 0.92(0.74-1.14) 0.84(0.65-1.07) 0.76(0.57-1.01) 0.61(0.43-0.86) 0.005
172 138 125 114 114
Age, sex, energy-adjusted HR 1.0 0.84(0.67-1.05) 0.80(0.64-1.01) 0.77(0.60-0.98) 0.80(0.62-1.02) 0.06
Multivariable HR (95%CI) 1.0 0.91(0.71-1.17) 0.85(0.64-1.13) 0.75(0.54-1.05) 0.67(0.45-0.99) 0.04
52 42 39 42 31
Age, sex, energy-adjusted HR 1.0 0.86(0.57-1.29) 0.84(0.56-1.29) 0.95(0.63-1.44) 0.74(0.47-1.17) 0.33
Multivariable HR (95%CI) 1.0 0.93(0.59-1.46) 0.85(0.51-1.43) 0.81(0.45-1.45) 0.49(0.24-1.02) 0.07
64 78 63 68 75
Age, sex, energy-adjusted HR 1.0 1.13(0.81-1.57) 0.87(0.61-1.24) 0.91(0.64-1.29) 1.00(0.70-1.41) 0.57
Multivariable HR (95%CI) 1.0 1.17(0.81-1.68) 0.91(0.59-1.39) 0.93(0.58-1.50) 0.87(0.50-1.52) 0.45
520 427 364 309 319
Age, sex, energy-adjusted HR 1.0 0.90(0.79-1.02) 0.85(0.74-0.97) 0.78(0.67-0.90) 0.86(0.74-0.99) 0.006
Multivariable HR (95%CI) 1.0 0.98(0.85-1.13) 0.94(0.80-1.11) 0.85(0.70-1.03) 0.84(0.67-1.06) 0.08
224 216 167 126 138
Age, sex, energy-adjusted HR 1.0 1.04(0.86-1.26) 0.88(0.72-1.08) 0.71(0.57-0.89) 0.83(0.67-1.03) 0.002
Multivariable HR (95%CI) 1.0 1.15(0.93-1.41) 0.97(0.76-1.25) 0.75(0.55-1.01) 0.75(0.53-1.07) 0.02
111 81 71 73 67
Age, sex, energy-adjusted HR 1.0 0.80(0.60-1.07) 0.78(0.58-1.06) 0.87(0.65-1.18) 0.86(0.63-1.18) 0.56
Multivariable HR (95%CI) 1.0 0.83(0.60-1.14) 0.80(0.55-1.16) 0.89(0.58-1.35) 0.81(0.49-1.34) 0.55
155 116 102 90 100
Age, sex, energy-adjusted HR 1.0 0.83(0.65-1.06) 0.82(0.64-1.05) 0.79(0.61-1.03) 0.95(0.73-1.22) 0.59
Multivariable HR (95%CI) 1.0 0.92(0.71-1.20) 0.96(0.70-1.30) 0.94(0.65-1.34) 1.04(0.69-1.58) 0.84
142 104 125 115 124
Age, sex, energy-adjusted HR 1.0 0.85(0.66-1.09) 1.17(0.92-1.49) 1.20(0.93-1.54) 1.41(1.10-1.81) <0.001
Multivariable HR (95%CI) 1.0 0.90(0.68-1.18) 1.24(0.92-1.67) 1.24(0.88-1.75) 1.39(0.93-2.08) 0.046
43 24 13 19 17
Age, sex, energy-adjusted HR 1.0 0.64(0.39-1.06) 0.40(0.21-0.75) 0.65(0.37-1.12) 0.64(0.36-1.13) 0.18
Multivariable HR (95%CI) 1.0 0.53(0.30-0.93) 0.29(0.14-0.60) 0.42(0.19-0.92) 0.39(0.15-0.99) 0.06
996 812 724 664 671
Age, sex, energy-adjusted HR 1.0 0.88(0.80-0.97) 0.86(0.78-0.94) 0.84(0.76-0.93) 0.90(0.82-1.00) 0.03
Multivariable HR (95%CI) 1.0 0.94(0.85-1.05) 0.91(0.81-1.03) 0.86(0.75-0.98) 0.82(0.69-0.96) 0.01
Lobar intraparenchymal hemorrhage
Total cardiovascular disease (n)
Median intake, g/d
†SFA intake was energy-adjusted by nutrient residual model.
Multivariable model includes age, sex, energy intake, cohort, cigarette smoking status, alcohol intake, body mass index, sports at
leisure time, walking and standing time, perceived mental stress, energy-adjusted dietary intakes of carbohydrate, protein,
cholesterol, vegetables, fruit, and calcium.
Total stroke (n)
Embolic infarction (n)
Lacunar Infarction (n)
Large artery occlusive infarction (n)
Myocardial infarction (n)
Sudden cardiac death (n)
Table 2. Age, sex and energy-adjusted and multivariate adjusted hazard ratios and 95% confidence intervals of incident
cardiovascular outcomes according to quintiles of saturated fatty acids intake, JPHC Study, 1993-2008.
Men and Women
Quintiles of SFA intake (g/day)†
Intraparenchymal hemorrhage (n)
Subarachnoid hemorrhage (n)
Ischemic stroke (n)
Deep intraparenchymal hemorrhage
  
0.8-11.7 11.8-14.8 14.9-17.7 17.8-21.5 21.6-96.7 p-value†
Median SFA intake‡, g/day 9.5 13.3 16.2 19.4 24.8
Number at risk 11,291 9,130 7,206 5,697 4,760
Age at baseline*, y 56.4(7.6) 56.2(7.7) 56.2(7.8) 56.6(7.8) 56.7(7.8) <0.001
Body mass index, kg/m2 23.4(3.0) 23.5(2.9) 23.6(3.0) 23.6(3.0) 23.8(3.1) <0.001
Systolic blood pressure¶, 135(18) 132(17) 131(17) 130(18) 130(17) <0.001
Diastolic blood pressure¶, 80(10) 79(11) 79(11) 79(11) 78(10) <0.001
Treatment for hypertension, % 20.2 18.2 18.0 16.4 17.1 <0.001
Treatment for diabetes, % 2.8 3.3 3.9 4.6 5.4 <0.001
Serum cholesterol¶, mg/dl 191(34) 197(35) 198(35) 197(34) 201(34) <0.001
Treatment for HC, % 3.5 3.3 3.3 2.6 2.9 0.009
Current smoker, % 52.0 47.9 45.5 43.7 40.8 <0.001
Current drinker, % 84.1 77.1 70.8 63.2 55.8 <0.001
Sports ≥3 times/wk, % 8.0 9.7 12.0 12.8 15.0 <0.001
Walking/standing ≥3 h/day, % 66.9 62.9 61.3 57.1 55.9 <0.001
High perceived mental stress, 17.5 18.7 18.3 18.5 17.7 0.13
Non-employed, % 7.1 8.0 9.5 10.9 10.7 <0.001
Mean energy intake, Kcal/day 2,190(709) 2,228(693) 2,208(721) 2,163(721) 2,181(826) <0.001
Dietary cholesterol, mg/day 230(150) 308(179) 343(212) 371(247) 421(346) <0.001
Protein, g/day 66(29) 77(31) 80(32) 82(33) 85(37) <0.001
Carbohydrate, g/day 300(101) 294(89) 283(85) 265(78) 240(83) <0.001
MUFA, g/day 15.1(7.8) 21.1(9.5) 24.3(11.1) 27.1(12.8) 33.0(18.6) <0.001
ω-3 PUFA, g/day 2.7(1.7) 3.4(2.0) 3.6(2.0) 3.6(2.0) 3.4(1.8) <0.001
ω-6 PUFA, g/day 7.7(3.8) 9.6(4.4) 10.3(4.7) 10.8(5.0) 11.6(6.0) <0.001
Salt, mg/day 12.2(6.6) 13.4(6.4) 13.4(6.4) 13.1(6.2) 12.4(6.0) <0.001
Calcium, mg/day 396(212) 504(238) 554(272) 600(328) 771(607) <0.001
Vegetable intake, g/day 192(173) 218(166) 219(154) 212(149) 196(150) <0.001
Fruit intake, g/day 179(214) 199(185) 200(179) 185(159) 151(139) <0.001
Meat intake, g/day 38(29) 61(41) 77(53) 90(65) 116(99) <0.001
Dairy intake, g/day 67(82) 130(115) 175(156) 225(222) 400(492) <0.001
Median SFA intake‡, g/day 10.0 13.6 16.4 19.5 25.0
Number at risk 5,095 7,256 9,181 10,689 11,626
Age at baseline*, y 59.3(7.7) 57.7(7.7) 56.9(7.7) 56.4(7.8) 55.8(7.9) <0.001
Body mass index, kg/m2 23.6(3.3) 23.6(3.3) 23.6(3.2) 23.4(3.2) 23.5(3.2) <0.001
Systolic blood pressure¶, 132(18) 130(17) 129(18) 129(17) 129(18) <0.001
Diastolic blood pressure¶, 77(11) 77(10) 77(10) 77(10) 76(10) 0.009
Treatment for hypertension, % 23.1 21.6 20.3 20.1 19.1 <0.001
Treatment for diabetes, % 2.2 2.2 2.2 2.3 2.6 0.10
Serum cholesterol¶, mg/dl 209(35) 212(35) 212(34) 214(34) 214(34) <0.001
Treatment for HC, % 7.3 7.4 7.3 6.3 6.0 <0.001
Current smoker, % 5.9 4.9 4.3 4.2 5.1 <0.001
Current drinker, % 16.9 17.7 16.7 17.5 15.0 <0.001
Sports ≥3 times/wk, % 6.6 8.2 10.6 11.4 13.4 <0.001
Walking/standing ≥3 h/day, % 67.4 68.3 67.9 66.5 65.3 <0.001
High perceived mental stress, 16.9 17.3 16.5 17.3 17.2 0.58
Non-employed, % 7.0 5.8 6.3 6.3 7.0 0.007
Mean energy intake, Kcal/day 1,683(649) 1,848(617) 1,889(594) 1,909(596) 1,924(693) <0.001
Protein, g/day 56(28) 68(29) 72(29) 75(29) 78(33) <0.001
Carbohydrate, g/day 277(100) 279(85) 269(75) 254(69) 226(73) <0.001
Dietary cholesterol, mg/day 169(126) 245(137) 287(152) 321(177) 361(254) <0.001
MUFA, g/day 12.7(7.6) 18.1(8.7) 21.0(9.5) 24.0(10.5) 29.1(15.1) <0.001
ω-3 PUFA, g/day 2.6(1.8) 3.3(1.9) 3.5(1.9) 3.6(1.9) 3.4(1.7) <0.001
ω-6 PUFA, g/day 7.1(4.2) 8.9(4.4) 9.6(4.3) 10.2(4.4) 10.8(5.2) <0.001
Salt, mg/day 11.5(7.0) 13.0(6.7) 12.9(6.2) 12.7(5.7) 12.0(5.7) <0.001
Calcium, mg/day 381(233) 491(255) 553(258) 601(279) 738(517) <0.001
Vegetable intake, g/day 232(225) 265(210) 256(183) 245(157) 219(147) <0.001
Fruit intake, g/day 289(314) 300(259) 279(221) 251(192) 200(166) <0.001
Meat intake, g/day 21(19) 40(28) 52(36) 67(46) 93(78) <0.001
Dairy intake, g/day 52(74) 114(102) 168(126) 216(158) 366(403) <0.001
¶ Only available for subsample (8,765 men and 16,047 women)
† p values for overall difference among quintiles based on analysis of covariance 
‡ Energy-adjusted values by nutrient residual model.
Table S-1.  Sex-specific baseline cardiovascular risk factors and selected dietary variables in a cohort of
38,084 men and 43,847 women according to quintiles of saturated fatty acid (SFA) intake.
Quintiles of SFA intake‡
Men
Women
HC: hypercholesterolemia, SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA:
polyunsaturated fatty acids
Age-adjusted means (unadjusted standard deviations), or age-adjusted percentages presented unless
otherwise indicated.
* Unadjusted mean
Q1 Q2 Q3 Q4 Q5 Trend p
9.6 13.4 16.3 19.4 24.9
Person-years 122,701 99,655 77,954 60,793 50,786
622 456 329 245 218
Age, sex, energy-adjusted HR 1.0 0.90(0.80-1.02) 0.84(0.73-0.96) 0.78(0.68-0.91) 0.82(0.71-0.96) 0.003
Multivariable HR (95%CI) 1.0 1.00(0.88-1.15) 0.94(0.80-1.10) 0.85(0.70-1.03) 0.80(0.63-1.01) 0.03
170 120 91 65 56
Age, sex, energy-adjusted HR 1.0 0.87(0.69-1.10) 0.85(0.66-1.09) 0.77(0.58-1.02) 0.79(0.58-1.06) 0.08
Multivariable HR (95%CI) 1.0 0.96(0.74-1.25) 0.91(0.67-1.24) 0.76(0.52-1.11) 0.64(0.41-1.01) 0.04
127 90 71 41 47
Age, sex, energy-adjusted HR 1.0 0.87(0.66-1.14) 0.88(0.66-1.18) 0.65(0.46-0.93) 0.89(0.63-1.24) 0.17
Multivariable HR (95%CI) 1.0 1.00(0.74-1.35) 1.02(0.72-1.46) 0.73(0.46-1.14) 0.85(0.51-1.41) 0.29
39 25 18 21 9
Age, sex, energy-adjusted HR 1.0 0.80(0.48-1.32) 0.74(0.42-1.29) 1.07(0.63-1.81) 0.54(0.26-1.12) 0.24
Multivariable HR (95%CI) 1.0 0.77(0.44-1.35) 0.62(0.31-1.22) 0.74(0.35-1.57) 0.29(0.10-0.82) 0.04
38 38 24 11 13
Age, sex, energy-adjusted HR 1.0 1.22(0.78-1.92) 0.99(0.59-1.65) 0.58(0.30-1.14) 0.82(0.44-1.54) 0.12
Multivariable HR (95%CI) 1.0 1.42(0.86-2.34) 1.21(0.65-2.26) 0.71(0.31-1.65) 0.95(0.37-2.43) 0.49
413 296 214 168 147
Age, sex, energy-adjusted HR 1.0 0.88(0.76-1.02) 0.82(0.70-0.97) 0.80(0.67-0.96) 0.83(0.69-1.00) 0.03
Multivariable HR (95%CI) 1.0 0.98(0.83-1.15) 0.92(0.75-1.13) 0.89(0.70-1.13) 0.85(0.63-1.13) 0.21
176 147 91 67 57
Age, sex, energy-adjusted HR 1.0 1.03(0.82-1.28) 0.82(0.63-1.05) 0.76(0.57-1.00) 0.76(0.56-1.02) 0.01
Multivariable HR (95%CI) 1.0 1.12(0.87-1.43) 0.89(0.66-1.21) 0.80(0.55-1.16) 0.72(0.46-1.13) 0.06
83 59 38 45 37
Age, sex, energy-adjusted HR 1.0 0.88(0.63-1.23) 0.73(0.50-1.07) 1.07(0.75-1.54) 1.04(0.70-1.53) 0.54
Multivariable HR (95%CI) 1.0 0.92(0.63-1.33) 0.74(0.46-1.17) 1.04(0.63-1.72) 0.91(0.49-1.69) 0.93
128 81 70 47 49
Age, sex, energy-adjusted HR 1.0 0.78(0.59-1.02) 0.86(0.65-1.16) 0.72(0.52-1.01) 0.89(0.64-1.23) 0.41
Multivariable HR (95%CI) 1.0 0.89(0.65-1.21) 1.04(0.73-1.49) 0.88(0.57-1.37) 1.03(0.62-1.72) 0.92
117 81 89 77 75
Age, sex, energy-adjusted HR 1.0 0.87(0.65-1.15) 1.22(0.92-1.60) 1.31(0.98-1.75) 1.51(1.13-2.02) 0.002
Multivariable HR (95%CI) 1.0 0.90(0.66-1.23) 1.25(0.89-1.76) 1.30(0.88-1.93) 1.41(0.88-2.26) 0.06
36 18 8 11 13
Age, sex, energy-adjusted HR 1.0 0.62(0.35-1.09) 0.35(0.16-0.76) 0.59(0.30-1.16) 0.82(0.43-1.55) 0.55
Multivariable HR (95%CI) 1.0 0.50(0.27-0.95) 0.25(0.10-0.62) 0.41(0.16-1.03) 0.54(0.18-1.57) 0.27
770 548 423 326 297
Age, sex, energy-adjusted HR 1.0 0.88(0.79-0.98) 0.87(0.77-0.98) 0.84(0.74-0.96) 0.91(0.79-1.04) 0.12
Multivariable HR (95%CI) 1.0 0.96(0.85-1.09) 0.95(0.82-1.10) 0.89(0.75-1.06) 0.86(0.70-1.06) 0.12
Sudden cardiac death (n)
Total cardiovascular disease (n)
Multivariable model includes age, sex, energy intake, cohort, cigarette smoking status, alcohol intake, body mass index, sports
at leisure time, walking and standing time, perceived mental stress, energy-adjusted dietary intakes of carbohydrate, protein,
cholesterol, vegetables, fruit, and calcium.
†SFA intake was energy-adjusted by nutrient residual model.
Large artery occlusive infarction (n)
Embolic infarction (n)
Myocardial infarction (n)
Intraparenchymal hemorrhage (n)
Deep intraparenchymal hemorrhage
Lobar intraparenchymal hemorrhage
Subarachnoid hemorrhage (n)
Ischemic stroke (n)
Lacunar Infarction (n)
Table S-2. Age and energy-adjusted and multivariate adjusted hazard ratios and 95% confidence intervals of incident
cardiovascular outcomes according to quintiles of saturated fatty acids intake, JPHC Study, 1993-2008, men.
Men
Quintiles of SFA intake (g/day)†
Median intake, g/d
Total stroke (n)
Q1 Q2 Q3 Q4 Q5 Trend p
9.6 13.4 16.3 19.4 24.9
Person-years 56,933 82,751 104,718 121,226 130,205
195 239 265 295 328
Age, sex, energy-adjusted HR 1.0 0.93(0.77-1.13) 0.86(0.71-1.03) 0.85(0.71-1.03) 0.92(0.77-1.11) 0.23
Multivariable HR (95%CI) 1.0 0.95(0.77-1.17) 0.84(0.67-1.06) 0.77(0.60-1.00) 0.72(0.53-0.97) 0.02
60 66 76 96 94
Age, sex, energy-adjusted HR 1.0 0.82(0.58-1.16) 0.77(0.55-1.09) 0.87(0.63-1.21) 0.82(0.59-1.15) 0.38
Multivariable HR (95%CI) 1.0 0.86(0.58-1.26) 0.73(0.47-1.12) 0.70(0.44-1.13) 0.58(0.33-1.00) 0.05
45 48 54 73 67
Age, sex, energy-adjusted HR 1.0 0.79(0.52-1.19) 0.73(0.49-1.08) 0.87(0.60-1.27) 0.77(0.53-1.14) 0.35
Multivariable HR (95%CI) 1.0 0.75(0.48-1.18) 0.60(0.36-0.98) 0.62(0.36-1.07) 0.47(0.25-0.90) 0.03
13 17 21 21 22
Age, sex, energy-adjusted HR 1.0 1.00(0.49-2.07) 1.03(0.51-2.06) 0.92(0.46-1.85) 0.94(0.47-1.88) 0.78
Multivariable HR (95%CI) 1.0 1.35(0.61-3.02) 1.38(0.57-3.33) 1.04(0.39-2.82) 0.92(0.29-2.85) 0.75
26 40 39 57 62
Age, sex, energy-adjusted HR 1.0 1.08(0.66-1.77) 0.84(0.51-1.39) 1.08(0.68-1.72) 1.11(0.70-1.76) 0.69
Multivariable HR (95%CI) 1.0 1.00(0.59-1.70) 0.75(0.41-1.36) 0.88(0.46-1.69) 0.75(0.36-1.59) 0.44
107 131 150 141 172
Age, sex, energy-adjusted HR 1.0 0.97(0.75-1.26) 0.94(0.73-1.20) 0.80(0.62-1.03) 0.95(0.75-1.22) 0.29
Multivariable HR (95%CI) 1.0 0.99(0.75-1.31) 0.96(0.70-1.31) 0.79(0.55-1.13) 0.82(0.54-1.23) 0.20
48 69 76 59 81
Age, sex, energy-adjusted HR 1.0 1.15(0.79-1.66) 1.07(0.74-1.54) 0.75(0.51-1.10) 1.01(0.70-1.45) 0.32
Multivariable HR (95%CI) 1.0 1.22(0.81-1.83) 1.08(0.68-1.71) 0.67(0.39-1.14) 0.75(0.41-1.38) 0.11
28 22 33 28 30
Age, sex, energy-adjusted HR 1.0 0.61(0.35-1.07) 0.77(0.46-1.27) 0.58(0.34-0.99) 0.61(0.36-1.03) 0.09
Multivariable HR (95%CI) 1.0 0.67(0.36-1.23) 0.91(0.48-1.72) 0.74(0.35-1.59) 0.69(0.28-1.69) 0.56
27 35 32 43 51
Age, sex, energy-adjusted HR 1.0 1.04(0.63-1.73) 0.81(0.48-1.35) 0.99(0.61-1.60) 1.15(0.72-1.85) 0.67
Multivariable HR (95%CI) 1.0 0.98(0.57-1.68) 0.80(0.43-1.49) 1.01(0.52-1.99) 1.09(0.50-2.40) 0.82
25 23 36 38 49
Age, sex, energy-adjusted HR 1.0 0.75(0.42-1.32) 0.99(0.59-1.66) 0.95(0.57-1.58) 1.20(0.73-1.95) 0.29
Multivariable HR (95%CI) 1.0 0.85(0.46-1.57) 1.14(0.60-2.18) 1.01(0.49-2.08) 1.18(0.51-2.69) 0.62
7 6 5 8 4
Age, sex, energy-adjusted HR 1.0 0.70(0.24-2.11) 0.50(0.16-1.60) 0.73(0.26-2.04) 0.36(0.10-1.25) 0.15
Multivariable HR (95%CI) 1.0 0.46(0.14-1.55) 0.25(0.06-1.04) 0.29(0.06-1.28) 0.14(0.02-0.97) 0.06
226 264 301 338 374
Age, sex, energy-adjusted HR 1.0 0.90(0.75-1.07) 0.85(0.71-1.01) 0.86(0.72-1.02) 0.92(0.78-1.09) 0.27
Multivariable HR (95%CI) 1.0 0.91(0.75-1.10) 0.83(0.67-1.03) 0.77(0.60-0.98) 0.72(0.54-0.95) 0.01
Sudden cardiac death (n)
Myocardial infarction (n)
Total cardiovascular disease (n)
Multivariable model includes age, sex, energy intake, cohort, cigarette smoking status, alcohol intake, body mass index, sports
at leisure time, walking and standing time, perceived mental stress, energy-adjusted dietary intakes of carbohydrate, protein,
cholesterol, vegetables, fruit, and calcium.
†SFA intake was energy-adjusted by nutrient residual model.
Large artery occlusive infarction (n)
Embolic infarction (n)
Intraparenchymal hemorrhage (n)
Deep intraparenchymal hemorrhage
Lobar intraparenchymal hemorrhage
Subarachnoid hemorrhage (n)
Ischemic stroke (n)
Lacunar Infarction (n)
Table S-3. Age and energy-adjusted and multivariate adjusted hazard ratios and 95% confidence intervals of incident
cardiovascular outcomes according to quintiles of saturated fatty acids intake, JPHC Study, 1993-2008, women.
Women
Quintiles of SFA intake (g/day)†
Median intake, g/d
Total stroke (n)
